Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. Schrijver LH, Mooij TM, Pijpe A, Sonke GS, et al. J Natl Cancer Inst 2022;114:540-552.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schrijver LH, Mooij TM, Pijpe A, Sonke GS, et al. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. J Natl Cancer Inst 2022;114:540-552.
PMID: 35048954